ENOCHIAN BIOSCIENCES INC's ticker is ENOB and the CUSIP is 29350E104. A total of 41 filers reported holding ENOCHIAN BIOSCIENCES INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,918 | +299.3% | 6,022 | -18.3% | 0.00% | – |
| Q1 2023 | $6,742 | +7.2% | 7,369 | +20.7% | 0.00% | – |
| Q4 2022 | $6,289 | -63.0% | 6,106 | +199.3% | 0.00% | – |
| Q1 2022 | $17,000 | +1600.0% | 2,040 | +1059.1% | 0.00% | – |
| Q4 2021 | $1,000 | – | 176 | +1073.3% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 15 | -94.2% | 0.00% | – |
| Q2 2021 | $1,000 | -92.3% | 260 | -92.7% | 0.00% | – |
| Q1 2021 | $13,000 | +30.0% | 3,551 | +4.7% | 0.00% | – |
| Q4 2020 | $10,000 | – | 3,391 | +4961.2% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 67 | -98.8% | 0.00% | – |
| Q2 2020 | $24,000 | -11.1% | 5,687 | -37.1% | 0.00% | – |
| Q1 2020 | $27,000 | -72.7% | 9,035 | -54.3% | 0.00% | – |
| Q4 2019 | $99,000 | +482.4% | 19,769 | +544.6% | 0.00% | – |
| Q3 2019 | $17,000 | +466.7% | 3,067 | +323.6% | 0.00% | – |
| Q2 2019 | $3,000 | -78.6% | 724 | -62.8% | 0.00% | – |
| Q4 2018 | $14,000 | – | 1,944 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 1,341,663 | $6,668,000 | 0.94% |
| Tibra Equities Europe Ltd | 41,900 | $208,000 | 0.06% |
| Virtu Financial LLC | 68,007 | $338,000 | 0.03% |
| Ergoteles LLC | 47,984 | $238,000 | 0.01% |
| Jacobi Capital Management LLC | 4,500 | $22,000 | 0.00% |
| HRT FINANCIAL LP | 41,058 | $204,000 | 0.00% |
| ETF MANAGERS GROUP, LLC | 14,099 | $72,000 | 0.00% |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | 47,691 | $237,000 | 0.00% |
| JANE STREET GROUP, LLC | 11,948 | $59,000 | 0.00% |
| UBS Group AG | 260 | $1,000 | 0.00% |